バイオシミュレーションの世界市場分析:製品別(ソフトウェア、サービス、社内サービス、契約サービス)、用途別(薬の開発、薬の発見)、エンドユーザー別(医薬品・バイオテクノロジー企業、CRO、規制当局、学術研究機関)、セグメント予測...市場調査レポートについてご紹介

【英文タイトル】Biosimulation Market Analysis By Product (Software, Services, In-house Services, Contract Services), By Application (Drug Development, Drug Discovery), By End-use (Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities, Academic Research Institutions) And Segment Forecasts To 2024

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Content

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
Chapter 3. Market Snapshot
Chapter 4. Market Variables, Trends & Scope
4.1. Market segmentation & scope
4.2. Market Driver Analysis
4.3. Market Restraint Analysis
4.4. Penetration & growth prospect mapping
4.5. Biosimulation – SWOT Analysis, By Factor (political & legal, economic and technological)
4.6. Industry Analysis – Porter’s
Chapter 5. Market Categorization 1: Product Estimates & Trend Analysis
5.1. Biosimulation market: Product movement analysis
5.2. Software
5.2.1. Software Market Estimates and Forecasts, 2013 – 2024 (USD Million)
5.3. Services
5.3.1. Services Market Estimates and Forecasts, 2013 – 2024 (USD Million)
5.3.2. In-house Services
5.3.2.1. In-house Services Market Estimates and Forecasts, 2013 – 2024 (USD Million)
5.3.3. Contract Services
5.3.3.1. Contract Services Market Estimates and Forecasts, 2013 – 2024 (USD Million)
Chapter 6. Market Categorization 2: Application Estimates & Trend Analysis
6.1. Biosimulation market: Application movement analysis
6.2. Drug Development
6.2.1. Drug Development Market Estimates and Forecasts, 2013 – 2024 (USD Million)
6.3. Drug Discovery
6.3.1. Drug Discovery Market Estimates and Forecasts, 2013 – 2024 (USD Million)
6.4. Others
6.4.1. Others Market Estimates and Forecasts, 2013 – 2024 (USD Million)
Chapter 7. Market Categorization 3: End-use Estimates & Trend Analysis
7.1. Biosimulation market: Application movement analysis
7.2. Pharmaceutical & Biotechnology Companies
7.2.1. Pharmaceutical &Biotechnology Companies Market Estimates and Forecasts, 2013 – 2024 (USD Million)
7.3. CROs
7.3.1. CROs Market Estimates and Forecasts, 2013 – 2024 (USD Million)
7.4. Regulatory Authorities
7.4.1. Regulatory Authorities Market Estimates and Forecasts, 2013 – 2024 (USD Million)
7.5. Academic Research Institutions
7.5.1. Academic Research Institutions Market Estimates and Forecasts, 2013 – 2024 (USD Million)
Chapter 8. Market Categorization 3: Regional Estimates & Trend Analysis, By Type & Application
8.1. Biosimulation Market Share by Region, 2015 & 2024
8.2. North America
8.2.1. North America Market Estimates and Forecasts, By Product, 2013 – 2024 (USD Million)
8.2.1.1. U.S. Market Estimates and Forecasts
8.2.1.2. Canada Market Estimates and Forecasts
8.2.2. North America Market Estimates and Forecasts, By Application, 2013 – 2024 (USD Million)
8.2.2.1. U.S. Market Estimates and Forecasts
8.2.2.2. Canada Market Estimates and Forecasts
8.2.3. North America Market Estimates and Forecasts, By End-use, 2013 – 2024 (USD Million)
8.2.3.1. U.S. Market Estimates and Forecasts
8.2.3.2. Canada Market Estimates and Forecasts
8.3. Europe
8.3.1. Europe Market Estimates and Forecasts, By Product, 2013 – 2024 (USD Million)
8.3.1.1. UK Market Estimates and Forecasts
8.3.1.2. Germany Market Estimates and Forecasts
8.3.2. Europe Market Estimates and Forecasts, By Application, 2013 – 2024 (USD Million)
8.3.2.1. UK Market Estimates and Forecasts
8.3.2.2. Germany Market Estimates and Forecasts
8.3.3. Europe Market Estimates and Forecasts, By End-use, 2013 – 2024 (USD Million)
8.3.3.1. UK Market Estimates and Forecasts
8.3.3.2. Germany Market Estimates and Forecasts
8.4. Asia Pacific
8.4.1. Asia Pacific Market Estimates and Forecasts, By Product, 2013 – 2024 (USD Million)
8.4.1.1. Japan Market Estimates and Forecasts
8.4.1.2. China Market Estimates and Forecasts
8.4.1.3. India Market Estimates and Forecasts
8.4.2. Asia Pacific Market Estimates and Forecasts, By Application, 2013 – 2024 (USD Million)
8.4.2.1. Japan Market Estimates and Forecasts
8.4.2.2. China Market Estimates and Forecasts
8.4.2.3. India Market Estimates and Forecasts
8.4.3. Asia Pacific Market Estimates and Forecasts, By End-use, 2013 – 2024 (USD Million)
8.4.3.1. Japan Market Estimates and Forecasts
8.4.3.2. China Market Estimates and Forecasts
8.4.3.3. India Market Estimates and Forecasts
8.5. Latin America
8.5.1. Latin America Market Estimates and Forecasts, By Product, 2013 – 2024 (USD Million)
8.5.1.1. Brazil Market Estimates and Forecasts
8.5.1.2. Mexico Market Estimates and Forecasts
8.5.2. Latin America Market Estimates and Forecasts, By Application, 2013 – 2024 (USD Million)
8.5.2.1. Brazil Market Estimates and Forecasts
8.5.2.2. Mexico Market Estimates and Forecasts
8.5.3. Latin America Market Estimates and Forecasts, By End-use, 2013 – 2024 (USD Million)
8.5.3.1. Brazil Market Estimates and Forecasts
8.5.3.2. Mexico Market Estimates and Forecasts
8.6. MEA
8.6.1. MEA Market Estimates and Forecasts, By Product, 2013 – 2024 (USD Million)
8.6.1.1. South Africa Market Estimates and Forecasts
8.6.2. MEA Market Estimates and Forecasts, By Application, 2013 – 2024 (USD Million)
8.6.2.1. South Africa Market Estimates and Forecasts
8.6.3. MEA Market Estimates and Forecasts, By End-use, 2013 – 2024 (USD Million)
8.6.3.1. South Africa Market Estimates and Forecasts
Chapter 9. Competitive Landscape
9.1. Strategy framework
9.2. Market participation categorization
9.3. Company Profiles
9.3.1. Certara USA, Inc.
9.3.1.1. Company Overview
9.3.1.2. Financial Performance
9.3.1.3. Product Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. Simulation Plus, Inc.
9.3.2.1. Company Overview
9.3.2.2. Financial Performance
9.3.2.3. Product Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. Dassault Systems SA
9.3.3.1. Company Overview
9.3.3.2. Financial Performance
9.3.3.3. Product Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Schrodinger, Inc.
9.3.4.1. Company Overview
9.3.4.2. Financial Performance
9.3.4.3. Product Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. Advanced Chemistry Development, Inc.
9.3.5.1. Company Overview
9.3.5.2. Financial Performance
9.3.5.3. Product Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Chemical Computing Group, Inc.
9.3.6.1. Company Overview
9.3.6.2. Financial Performance
9.3.6.3. Product Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Physiomics PLC
9.3.7.1. Company Overview
9.3.7.2. Financial Performance
9.3.7.3. Product Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. Entelos, Inc.
9.3.8.1. Company Overview
9.3.8.2. Financial Performance
9.3.8.3. Product Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. Rhenovia Pharma Ltd.
9.3.9.1. Company Overview
9.3.9.2. Financial Performance
9.3.9.3. Product Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. Genedata AG
9.3.10.1. Company Overview
9.3.10.2. Financial Performance
9.3.10.3. Product Benchmarking
9.3.10.4. Strategic Initiatives
9.3.11. Leadscope, Inc.
9.3.11.1. Company Overview
9.3.11.2. Financial Performance
9.3.11.3. Product Benchmarking
9.3.11.4. Strategic Initiatives
9.3.12. Evidera, Inc.
9.3.12.1. Company Overview
9.3.12.2. Financial Performance
9.3.12.3. Product Benchmarking
9.3.12.4. Strategic Initiatives
9.3.13. Insilico Biotechnology AG
9.3.13.1. Company Overview
9.3.13.2. Financial Performance
9.3.13.3. Product Benchmarking
9.3.13.4. Strategic Initiatives
9.3.14. LeadInvent Technologies Pvt. Ltd.
9.3.14.1. Company Overview
9.3.14.2. Financial Performance
9.3.14.3. Product Benchmarking
9.3.14.4. Strategic Initiatives
9.3.15. InhibOx Ltd.
9.3.15.1. Company Overview
9.3.15.2. Financial Performance
9.3.15.3. Product Benchmarking
9.3.15.4. Strategic Initiatives


【レポート販売概要】

■ タイトル:バイオシミュレーションの世界市場分析:製品別(ソフトウェア、サービス、社内サービス、契約サービス)、用途別(薬の開発、薬の発見)、エンドユーザー別(医薬品・バイオテクノロジー企業、CRO、規制当局、学術研究機関)、セグメント予測
■ 英文:Biosimulation Market Analysis By Product (Software, Services, In-house Services, Contract Services), By Application (Drug Development, Drug Discovery), By End-use (Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities, Academic Research Institutions) And Segment Forecasts To 2024
■ 発行日:2016年8月21日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707129
■ 調査対象地域:グローバル
  • Woodside Petroleum Limited:石油・ガスの開発・生産動向及びコスト分析- Q2, 2013
    Woodside Petroleum Limited Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Woodside Petroleum Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essent …
  • 太陽光発電用マイクロインバータ―(ソーラーマイクロインバータ―)の世界市場2018-2022
    About Solar Microinverter Solar microinverters convert direct current (DC) from solar panels into alternate current (AC) of the required frequency. The output from several microinverters is later combined and fed to electrical grids to generate power. Technavio’s analysts forecast the global solar microinverter market to grow at a CAGR of 15.54% during the period 2018-2022. Covered in this report …
  • 機内エンターテイメントシステムの世界市場2015-2019
    About In-flight IFE systems are integral value additions for airlines, primarily on long routes. While IFE systems have been around for some time, the move toward providing in-flight connectivity is relatively new. These services enable passengers to enjoy their in-flight time through a host of programs such as games and movies, and enable airlines to effectively engage their passengers and gain a …
  • Fabry Disease:グローバル臨床試験レビューH1, 2013
    Fabry Disease Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “ Fabry Disease Global Clinical Trials Review, H1, 2013" provides data on the Fabry Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fabry Disease. It includes an overview of the trial numbers and their recruitment status as per th …
  • 偏頭痛(Migraine):グローバル医薬品市場予測及び分析(~2023)
    PharmaPoint: Migraine - Global Drug Forecast and Market Analysis to 2023 Summary The migraine market is saturated with generic drugs, and the remaining branded products already on the market are expected to lose exclusivity during the next few years, with the exception of Botox for chronic migraine, which is expected to maintain its leading position in terms of sales. However, reformulations of ma …
  • 呼吸抑制(Respiratory Depression):世界の治験レビュー2014年下半期版
    Respiratory Depression Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Respiratory Depression Global Clinical Trials Review, H2, 2014" provides data on the Respiratory Depression clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Respiratory Depression. It includes an overview of the trial numbers and …
  • ヨーロッパのOrganic Fertilizers市場
    The report provides a complete overview of the organic fertilizers market in EU countries in a comprehensive and easily accessed format. Market current state, historical figures and future development are in the report. Scope The report gives in-depth analysis of the European Union market for organic fertilizers with data for EU in total and by country Current statistics, historical background and …
  • 紙包装の世界市場
    Visiongain’s comprehensive new 209-page report reveals that the global paper packaging market will reach a value of $303.8 billion in 2018. As such paper packaging still dominates the packaging landscape in many consumer verticals and industrial applications due to its light weight and highly recyclable nature. Are you involved in the paper packaging market or intend to be? If so, then you must re …
  • 世界のシステム管理ソフト市場動向(2012-2016)
    TechNavio’s analysts forecast the Global Systems Management Software market to grow at a CAGR of 6.17 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need to enhance employee productivity and reduce costs. The Global Systems Management Software market has also been witnessing the emergence of cloud-based systems management solutions. However, man …
  • 食物アレルギー(Food Allergy):治療薬開発パイプライン動向(2015年上半期版)
    Food Allergy - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Food Allergy - Pipeline Review, H1 2015’, provides an overview of the Food Allergy’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Food Allergy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), ro …
  • 2014年戦略提言:ヨーロッパのHIV/AIDS診断検査市場
    Complete report $3,950.  DataPack (test volumes, sales forecasts, supplier shares) $2,500.Summary This 5-country report presents detailed analyses of the AIDS diagnostics market in Europe (France, Germany, Italy, Spain, UK).  For each country, the report provides test volume and sales forecasts for HIV-1/2, HIV Ag, NAT, Western Blot and other confirmatory tests performed in the following …
  • がんバイオマーカーの世界市場分析:タイプ別(乳房、前立腺、結腸直腸、子宮頸、肝臓、肺)、生体分子別(遺伝的、後天的、代謝、プロテオーム)、用途別、セグメント予測、2014 – 2025
    The global cancer biomarkers market is expected to reach a value of USD 33.7 billion by 2025, based on a new report by Grand View Research, Inc. Growing initiatives for development of drugs targeting novel cancer biomarkers coupled with the introduction of technologically advanced companion diagnostic kits is estimated to provide the market with high growth potential. Increasing awareness about pe …
  • Bonterra Energy Corp:石油・ガスの開発・生産動向及びコスト分析- Q2, 2013
    Bonterra Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Bonterra Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source f …
  • グローバルにおける火力発電所の刷新及び現代化
    Renovation and Modernization of Thermal Power Plants Summary Renovation and Modernization (R&M) refers to a set of activities intended to improve the performance and reliability of existing power-generation facilities, and is a cost-effective alternative to increasing the operational life of Thermal Power Plants (TPP). Through R&M, obsolete generation equipment undergoes technological upgrades to …
  • 建築用シーラントの世界市場:シリコーンシーラント、ポリウレタンシーラント、ポリスルフィドシーラント
    The report covers the global construction sealants market and further segments the market on the basis of type, technology, application, and region. The market data for these types is given with respect to volume (thousand tons) and value ($million). The global market value of construction sealants was estimated to be about $8.93 billion in 2020 and is projected to grow at a CAGR 5.59% between 201 …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。